A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting

• Κύριοι συγγραφείς: Zindel Sonja (Συγγραφέας), Stock Stephanie (Συγγραφέας), Müller Dirk (Συγγραφέας), Stollenwerk Björn (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: BMC, 2012-07-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Patients undergoing major orthopaedic surgery (MOS), such as total hip (THR) or total knee replacement (TKR), are at high risk of developing venous thromboembolism (VTE). For thromboembolism prophylaxis, the oral anticoagulant rivaro...